drugset / Trial / NCT05424692

Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer

NCT05424692

Recruiting 200 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The research objectives is to compare vitro 3D drug sensitivity test results of micro tumor (PTC) with the clinical outcomes of patients, evaluate the consistency between the test results of the technology platform and the clinical prognosis, and explore the decision-making value and guiding significance of this technology in assisting the precise treatment of colorectal cancer. The completion of this study will provide real-world data support for the clinical application of micro tumor (PTC) in vitro 3D drug sensitivity detection technology, and provide more valuable reference basis for realizing the individualization and accuracy of colorectal cancer treatment and improving the clinical benefit rate.

Timeline

Start
2021-09-01
Primary completion
2025-09-01
Completion
2027-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetuximab Monoclonal antibody
Subject Irinotecan Small molecule
Subject Oxaliplatin Small molecule
Subject S-1 Small molecule
Subject fluorouracil Small molecule